Open Access

Q&A - What have we learned from SGLT-2 inhibitors in heart failure?

logo

Congress Presentation

About the speakers

Professor Seok Min Kang

Yonsei University, Seoul (Korea (Republic of))
5 presentations
0 follower

Professor Ricardo Fontes Carvalho

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
28 presentations
7 followers

3 more presentations in this session

Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Thumbnail

What have we learned from SGLT-2 Inhibitors in Heart Failure?

Speaker: Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Thumbnail

Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Thumbnail

Access the full session

What have we learned from SGLT-2 inhibitors in heart failure?

Speakers: Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb